LINKING MASLD AND CVD

Muhammad Shahzeb Khan, MD, MSc; Syed Sarmad Javaid, MBBS; Amreen Dinani, MD; Kara Wegermann, MD; Ambarish Pandey, MD; Ankeet S. Bhatt, MD, MBA, ScM; Mark Muthiah, MBBS; Harriette G.C. Van Spall, MD, MPH; Faiez Zannad, MD, PhD; Javed Butler, MD, MPH, MBA;

Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a multisystem disease that is closely linked to cardiovascular disease, which remains a leading cause of mortality. The document discusses the shared pathophysiological mechanisms between MASLD and cardiovascular disease, including insulin resistance and chronic inflammation. It highlights the importance of integrated care and the role of cardiologists in early detection and management of MASLD, as well as the latest therapeutic options and lifestyle interventions.